Home
>
National Drug Code (NDC)
>
Norpace
Norpace - 0025-2742-31 - (disopyramide phosphate)
Drug Information of Norpace
| Product NDC: | 0025-2742 |
| Proprietary Name: | Norpace |
| Non Proprietary Name: | disopyramide phosphate |
| Active Ingredient(s): | 150 mg/1 & nbsp; disopyramide phosphate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, GELATIN COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Norpace
| Product NDC: | 0025-2742 |
| Labeler Name: | G.D. Searle LLC Division of Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018655 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19820720 |
Package Information of Norpace
| Package NDC: | 0025-2742-31 |
| Package Description: | 100 CAPSULE, GELATIN COATED in 1 BOTTLE (0025-2742-31) |
NDC Information of Norpace
| NDC Code | 0025-2742-31 |
| Proprietary Name | Norpace |
| Package Description | 100 CAPSULE, GELATIN COATED in 1 BOTTLE (0025-2742-31) |
| Product NDC | 0025-2742 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | disopyramide phosphate |
| Dosage Form Name | CAPSULE, GELATIN COATED |
| Route Name | ORAL |
| Start Marketing Date | 19820720 |
| Marketing Category Name | NDA |
| Labeler Name | G.D. Searle LLC Division of Pfizer Inc |
| Substance Name | DISOPYRAMIDE PHOSPHATE |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antiarrhythmic [EPC] |
